Skip to main navigation Skip to search Skip to main content

SUNSCAPE-2: A Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants with Moderately to Severely Active Ulcerative Colitis

Grants and Contracts Details

StatusActive
Effective start/end date4/9/26 → 4/9/28

Funding

  • Sanofi US Services Incorporated: $2.00